As the cannabis industry faces increasing pressure, optimism is building around the potential for federal cannabis rescheduling.
During an interview at the recent Benzinga Cannabis Capital Conference, Cresco Labs CEO Charlie Bachtell spoke about the impact of rescheduling, highlighting it as the initial move toward long-term federal normalization.
Bachtell stressed the importance of rescheduling cannabis under federal law, calling it “the first step in finally having federal normalization” for the cannabis industry.
Rescheduling on the Horizon
Completing the rescheduling process would be critical in allowing businesses to operate under more conventional financial and tax systems, Bachtell says.
This change could help companies “grow and continue normally” while eliminating unnecessary burdens imposed on the industry, he added.
The Cresco Labs executive pointed to widespread public …
Full story available on Benzinga.com